ARase Therapeutics is a newly formed, science-focused oncology company developing first-in-class drugs that modulate cell signaling pathways. We are seeking highly motivated, intelligent and creative individuals who want to make an early and lasting impact on an actively growing company.
- Paul Chang President, CEO / CSO and founder
- Lisa Ames Protein and Assay Biology
- Muzhou Wu Translational Biology
- Katherine Widdowson Chemistry